NASDAQ
16.10.26 | 20:40
1,090 US-Dollar
+2,83 % +0,030
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 05.10. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 8 | SEC Filings | ||
| 18.09. | Full Transcript: Icecure Medical Q2 2026 Earnings Call | 3 | Benzinga.com | ||
| 11.09. | IceCure Secures China NMPA Approval for ProSense Cryoablation System | 1 | Zacks | ||
| 10.09. | IceCure Medical wins China approval for ProSense cryoablation system | 2 | Seeking Alpha | ||
| 10.09. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 24.08. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.08. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 12.08. | IceCure Medical GAAP EPS of -$3.17 misses by $1.65, revenue of $1.82M beats by $0.37M | 3 | Seeking Alpha | ||
| 12.08. | IceCure Medical: IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year | 269 | PR Newswire | The Company is advancing commercial execution and expanding its U.S. commercial footprint through approximately 70% growth in its active installed base following... ► Artikel lesen | |
| 06.08. | IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment | 208 | PR Newswire | Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signing both an agreement and receiving IRB approval
The site will... ► Artikel lesen | |
| 26.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 26.06. | What's Going On With IceCure Medical Stock On Friday? | 6 | Benzinga.com | ||
| 25.06. | IceCure Medical: IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement | 197 | PR Newswire | CAESAREA, Israel, June 25, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive... ► Artikel lesen | |
| 18.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.06. | IceCure Medical: IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance | 542 | PR Newswire | Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Significant rise in number of leads for ProSense® systems generated... ► Artikel lesen | |
| 02.06. | IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance | 1 | Seeking Alpha | ||
| 02.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.06. | IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance | 478 | PR Newswire | Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy
CAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical... ► Artikel lesen | |
| 19.05. | IceCure Medical: IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked | 313 | PR Newswire | At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors =3 cm and... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,750 | +3,49 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler und TerThera unterzeichnen Liefervertrag, der brasilianischen Patienten GMP-konforme Terbium-161-Radiopharmaka der nächsten Generation zugänglich macht. | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vertrag
Eckert & Ziegler und TerThera unterzeichnen Liefervertrag, der brasilianischen Patienten GMP-konforme Terbium-161-Radiopharmaka... ► Artikel lesen | |
| LANTHEUS | 88,90 | -0,45 % | Lantheus Holdings, Inc. - 8-K, Current Report | ||
| FRESENIUS | 45,075 | +2,78 % | VW und Autobauer im Fokus: DAX vor dem nächsten Schub? Diese Woche wird für Anleger entscheidend | © Foto: Boris Roessler/dpaDer DAX dürfte freundlich in die neue Woche starten. Auch die europäischen Futures liegen im Plus. Doch Öl, Inflation und die beginnende US-Berichtssaison könnten schnell für... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,450 | +1,47 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,540 | +0,20 % | CFO-News: Aumovio, Fresenius Medical Care, Verbund | ||
| BRIGHTSPRING HEALTH SERVICES | 60,89 | +0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,340 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| GERRESHEIMER | 30,440 | +6,06 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
12.10.2026 / 17:29 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| SANARA MEDTECH | 33,160 | 0,00 % | Sanara MedTech/MiMedx deal spread widens on FTC second request | ||
| ADAPTHEALTH | 6,020 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| HEARTFLOW | 48,265 | -0,05 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,730 | -0,09 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| PROGYNY | 26,875 | 0,00 % | Progyny, Inc.: Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting | ||
| ALIGNMENT HEALTHCARE | 8,300 | +0,24 % | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027 | ||
| DRAEGERWERK | 95,70 | -0,62 % | Drägerwerk Aktie bricht um fast 15 Prozent ein - Experte bleibt bei Kaufempfehlung | Die Drägerwerk Aktie verliert aktuell 14,67 Prozent auf 99,50 Euro, nachdem der Medizin- und Sicherheitstechnikkonzern mit seinen vorläufigen Quartalszahlen eine schwache operative Ergebnisentwicklung... ► Artikel lesen |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,030 (+2,83 %) liegt der Kurs bei 1,090 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.